Quantcast
Home > Quotes > ASRT
ASRT

Assertio Therapeutics, Inc. Common Stock (DE) (ASRT) Quote & Summary Data

$5.36
*  
0.03
0.56%
Get ASRT Alerts
*Delayed - data as of Nov. 20, 2018  -  Find a broker to begin trading ASRT now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
N/A / N/A
1 Year Target
8
Today's High / Low
$ 5.51 / $ 5.243
Share Volume
1,260,231
50 Day Avg. Daily Volume
604,919
Previous Close
$ 5.39
52 Week High / Low
$ 9.48 / $ 4.69
Market Cap
342,713,394
P/E Ratio
19.14
Forward P/E (1y)
NE
Earnings Per Share (EPS)
$ 0.28
Annualized Dividend
N/A
Ex Dividend Date
N/A
Dividend Payment Date
N/A
Current Yield
0 %
Beta
0

Intraday Chart

Shares Traded

Share Volume:
1,260,231
50 Day Avg. Daily Volume:
604,919

P/E Ratio

P/E Ratio:
19.14
Forward P/E (1y):
NE
Earnings Per Share (EPS):
$ 0.28

Trading Range

The current last sale of $5.36 is 14.29% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 5.51 $ 9.48
 Low: $ 5.243 $ 4.69

Company Description (as filed with the SEC)

Depomed is a specialty pharmaceutical company focused on pain and other central nervous system (CNS) conditions. Our current specialty pharmaceutical business includes the following three products which we market in the United States (U.S.): · Gralise® (gabapentin), a once­daily product for the management of postherpetic neuralgia (PHN), that we launched in October 2011. · CAMBIA® (diclofenac potassium for oral solution), a non­steroidal anti­inflammatory drug for the acute treatment of migraine attacks, that we acquired in December 2013. · Zipsor® (diclofenac potassium) liquid filled capsules, a non­steroidal anti­inflammatory drug for the treatment of mild to moderate acute pain, that we acquired in June 2012.  ... More ...  


Risk Grade

Where does ASRT fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 5.34
Open Date:
Nov. 20, 2018
Close Price:
$ 5.36
Close Date:
Nov. 20, 2018

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x